Zobrazeno 1 - 10
of 271
pro vyhledávání: '"Deng YN"'
Autor:
Liu, Hao-Li, Li, Meng-Lin, Shih, Tzu-Ching, Huang, Sheng-Min, Lu, I-Yeh, Lin, Deng-Yn, Lin, Shi-Ming, Ju, Kuen-Cheng
Publikováno v:
In Ultrasound in Medicine & Biology 2009 35(10):1647-1661
Publikováno v:
In Journal of the Chinese Medical Association 2007 70(8):310-317
Autor:
Chen, Chien-Hung, Chen, Yang Yuan, Chen, Gran-Hum, Yang, Sien-Sing, Tang, Huang-Shang, Lin, Hsien Hong, Lin, Deng-Yn, Lo, Sing Kai, Du, Jeng-Ming, Chang, Ting-Tsung, Chen, Shinn-Cherng, Liao, Li-Ying, Kuo, Chung-Huang, Lin, Kwo-Chuan, Tai, Dar-In ∗, Changchien, Chi-Sin, Chang, Wen-Yu, Sheu, Jin-Chuan, Chen, Ding-Shinn, Liaw, Yun-Fan, Sung, Juei-Low
Publikováno v:
In Journal of Hepatology 2004 40(4):653-659
Publikováno v:
BMC Medical Genomics, Vol 2, Iss 1, p 51 (2009)
Abstract Background The pathogenesis of inflammation and fibrosis in chronic hepatitis C virus (HCV) infection remains unclear. Transgenic mice with constitutive HCV core over-expression display steatosis only. While the reasons for this are unclear,
Externí odkaz:
https://doaj.org/article/94bec8725d6943618d5f7f23f3c8a758
Autor:
Chang Ming-Ling, Yeh Chau-Ting, Chen Jeng-Chang, Huang Chau-Chun, Lin Shi-Ming, Sheen I-Shyan, Tai Dar-In, Chu Chia-Ming, Lin Wei-Pin, Chang Ming-Yu, Liang Chun-Kai, Chiu Cheng-Tang, Lin Deng-Yn
Publikováno v:
BMC Genomics, Vol 9, Iss 1, p 109 (2008)
Abstract Background Because the gene expression patterns of nonobese hepatic steatosis in affected patients remain unclear, we sought to explore these patterns using an animal model of nonobese hepatic steatosis. Methods We developed mice that condit
Externí odkaz:
https://doaj.org/article/54950e5f2dd1424388a31e8423d40455
Autor:
Julia Hocke, Deng Yn Lin, Yin Hsun Feng, Dennis Chin-Lun Huang, Baek Yeol Ryoo, Ann-Lii Cheng, Yee Chao, Chia Jui Yen, Tae-You Kim, Arsene Bienvenu Loembe, David Schnell
Publikováno v:
Liver cancer. 7(2)
Background: Nintedanib is an oral, triple angiokinase inhibitor of vascular endothelial growth factor/platelet-derived growth factor/fibroblast growth factor receptors. This randomized, multicenter, open-label, phase I/II study evaluated the safety,
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Silvana Lanzalone, Deng Yn Lin, Masatoshi Kudo, Maria Jose Lechuga, Guido Poggi, Susan Pitman Lowenthal, Liqiang Yang, Ann-Lii Cheng, Jianming Xu, Hyun Cheol Chung, Xiangqun Song, Eric Raymond, Shukui Qin, Joong-Won Park, Masao Omata, Yoon-Koo Kang
Publikováno v:
Scopus-Elsevier
Purpose Open-label, phase III trial evaluating whether sunitinib was superior or equivalent to sorafenib in hepatocellular cancer. Patients and Methods Patients were stratified and randomly assigned to receive sunitinib 37.5 mg once per day or sorafe
Autor:
Jau‑Min Lien, Ji-Hong Hong, Bing Shen Huang, Wei-Ting Chen, Chen‑Chun Lin, Ngan Ming Tsang, Wan-Yu Chen, Deng‑Yn Lin, Shi-Ming Lin
Publikováno v:
Oncology Letters
Hypofractionated radiotherapy (RT) has been employed to treat hepatocellular carcinoma (HCC). The present study aimed to report the treatment effects, the dose-response associations and the factors that are associated with radiation-induced liver dis
Publikováno v:
The Journal of Infectious Diseases, 1994 Aug 01. 170(2), 358-361.
Externí odkaz:
https://www.jstor.org/stable/30134714